PetMed Express (NASDAQ:PETS) Stock Price Down 12.7% on Disappointing Earnings
Shares of PetMed Express, Inc. (NASDAQ:PETS) traded down 12.7% during mid-day trading on Tuesday after the company announced weaker than expected quarterly earnings. The stock traded as low as $30.03 and last traded at $30.33. 2,484,077 shares changed hands during trading, an increase of 226% from the average session volume of 762,462 shares. The stock had previously closed at $34.73.The company reported $0.38 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.39 by ($0.01). PetMed Express had a net margin of 9.82% and a return on equity of 22.79%. The firm had revenue of $65.90 million during the quarter, compared to analyst estimates of $63.81 million. During the same period in the prior year, the company earned $0.34 EPS. The business’s quarterly revenue was up 10.0% compared to the same quarter last year.
In other news, Director Ronald J. Korn sold 2,000 shares of PetMed Express stock in a transaction on Wednesday, January 13th. The shares were sold at an average price of $35.00, for a total transaction of $70,000.00. Following the transaction, the director now owns 83,333 shares in the company, valued at $2,916,655. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders have sold 8,000 shares of company stock valued at $268,000 in the last ninety days. Insiders own 3.60% of the company’s stock.
Hedge funds have recently modified their holdings of the company. JPMorgan Chase & Co. boosted its stake in shares of PetMed Express by 0.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 51,520 shares of the company’s stock valued at $1,617,000 after purchasing an additional 413 shares in the last quarter. Sowell Financial Services LLC lifted its stake in PetMed Express by 157.0% in the fourth quarter. Sowell Financial Services LLC now owns 771 shares of the company’s stock worth $25,000 after purchasing an additional 471 shares during the last quarter. Nuveen Asset Management LLC boosted its position in PetMed Express by 0.7% during the second quarter. Nuveen Asset Management LLC now owns 78,429 shares of the company’s stock valued at $2,795,000 after buying an additional 555 shares during the period. Cubist Systematic Strategies LLC boosted its position in PetMed Express by 2.5% during the second quarter. Cubist Systematic Strategies LLC now owns 23,503 shares of the company’s stock valued at $838,000 after buying an additional 577 shares during the period. Finally, Private Advisor Group LLC bought a new position in shares of PetMed Express during the second quarter valued at about $39,000. 91.59% of the stock is owned by institutional investors.
The company has a market cap of $614.85 million, a P/E ratio of 20.21 and a beta of 0.70. The business has a 50 day moving average price of $31.90 and a two-hundred day moving average price of $32.06.
About PetMed Express (NASDAQ:PETS)
PetMed Express, Inc, together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventative, flea and tick preventative, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Read More: Cash Asset Ratio
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]